Nordic Pharma Consulting ApS: Financial statements 2020
CVR: 37368598
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 8,895,814 and a net result of DKK 1,519,615 compared with DKK 751,731 the year before. That is an increase of 3.5% compared with the year before. Equity in the 2020 report amounted to DKK 2,322,212. The solvency ratio was 50.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 8,895,814
- Profit/Loss
- DKK 1,519,615
- Equity
- DKK 2,322,212
- Total Assets
- DKK 4,622,628
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 8.9M | 1.5M | 2.3M | 5 |
| 2019 | - | 8.6M | 752K | 803K | - |
| 2018 | - | 7M | 493K | 748K | - |
| 2017 | - | 6M | 785K | 855K | - |
| 2016 | - | 1.7M | 620K | 670K | - |
Official annual report
How creditworthy is Nordic Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Nordic Pharma Consulting ApS has published its annual report for 2019. Gross profit came to DKK 8,594,718, and the net result was DKK 751,731.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.